David Mulham's most recent trade in Usana Health Sciences Inc was a trade of 873 Common Stock done at an average price of $21 . Disclosure was reported to the exchange on Dec. 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 10 Dec 2025 | 873 | 8,387 (0%) | 0% | 21 | 18,333 | Common Stock | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 30 Jul 2025 | 3,515 | 9,260 (0%) | 0% | 30.3 | 106,364 | Common Stock | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 10 Mar 2025 | 3,234 | 12,775 (0%) | 0% | 33.0 | 106,670 | Common Stock | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 27 Feb 2025 | 18,641 | 32,671 | - | - | Restricted Stock Units | ||
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 08 Feb 2025 | 2,573 | 16,009 (0%) | 0% | - | Common Stock | ||
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 08 Feb 2025 | 2,573 | 14,030 | - | - | Restricted Stock Units | ||
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 08 Feb 2025 | 1,677 | 16,603 | - | - | Restricted Stock Units | ||
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 08 Feb 2025 | 1,677 | 13,436 (0%) | 0% | - | Common Stock | ||
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 06 Feb 2025 | 2,377 | 19,837 | - | - | Restricted Stock Units | ||
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 06 Feb 2025 | 2,377 | 10,202 (0%) | 0% | - | Common Stock | ||
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 06 Feb 2025 | 1,557 | 11,759 (0%) | 0% | - | Common Stock | ||
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 06 Feb 2025 | 1,557 | 18,280 | - | - | Restricted Stock Units | ||
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 29 Feb 2024 | 4,311 | 7,825 (0%) | 0% | 47.8 | 205,872 | Common Stock | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 08 Feb 2024 | 10,293 | 22,214 | - | - | Restricted Stock Units | ||
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 08 Feb 2024 | 1,676 | 12,136 (0%) | 0% | - | Common Stock | ||
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 08 Feb 2024 | 1,676 | 11,921 | - | - | Restricted Stock Units | ||
| Usana Health Sciences Inc | Mulham David | CHIEF SALES OFFICER | 06 Feb 2024 | 2,377 | 8,904 (0%) | 0% | - | Common Stock | ||
| Usana Health Sciences Inc | Mulham David | CHIEF SALES OFFICER | 06 Feb 2024 | 2,377 | 15,153 | - | - | Restricted Stock Units | ||
| Usana Health Sciences Inc | Mulham David | CHIEF SALES OFFICER | 06 Feb 2024 | 1,556 | 10,460 (0%) | 0% | - | Common Stock | ||
| Usana Health Sciences Inc | Mulham David | CHIEF SALES OFFICER | 06 Feb 2024 | 1,556 | 13,597 | - | - | Restricted Stock Units | ||
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 03 Feb 2024 | 1,079 | 6,527 (0%) | 0% | - | Common Stock | ||
| Usana Health Sciences Inc | Mulham David | CHIEF SALES OFFICER | 03 Feb 2024 | 1,079 | 17,530 | - | - | Restricted Stock Units | ||
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 15 Aug 2023 | 2,159 | 5,448 (0%) | 0% | 65.3 | 141,067 | Common Stock | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 11 Aug 2023 | 1,080 | 7,607 (0%) | 0% | 66.3 | 71,585 | Common Stock | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 31 Jul 2023 | 3,354 | 8,687 (0%) | 0% | 65 | 218,010 | Common Stock | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 15 Jun 2023 | 1,557 | 12,041 (0%) | 0% | 61 | 94,977 | Common Stock | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 28 Apr 2023 | 1,138 | 13,598 (0%) | 0% | 67.4 | 76,699 | Common Stock | |
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 06 Feb 2023 | 9,508 | 21,843 | - | - | Restricted Stock Units | ||
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 06 Feb 2023 | 1,677 | 14,736 (0%) | 0% | - | Common Stock | ||
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 06 Feb 2023 | 1,677 | 18,609 | - | - | Restricted Stock Units | ||
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 06 Feb 2023 | 1,557 | 20,286 | - | - | Restricted Stock Units | ||
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 06 Feb 2023 | 1,557 | 13,059 (0%) | 0% | - | Common Stock | ||
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 03 Feb 2023 | 1,138 | 12,335 | - | - | Restricted Stock Units | ||
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 03 Feb 2023 | 1,138 | 11,502 (0%) | 0% | - | Common Stock | ||
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 03 Feb 2023 | 1,080 | 10,364 (0%) | 0% | - | Common Stock | ||
| Usana Health Sciences Inc | David Mulham | CHIEF SALES OFFICER | 03 Feb 2023 | 1,080 | 13,473 | - | - | Restricted Stock Units | ||
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | 07 Feb 2022 | 6,226 | 16,230 | - | - | Restricted Stock Units | ||
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | 07 Feb 2022 | 1,677 | 14,553 | - | - | Restricted Stock Units | ||
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | 07 Feb 2022 | 1,677 | 9,374 (0%) | 0% | - | Common Stock | ||
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | 03 Feb 2022 | 1,399 | 10,004 | - | - | Restricted Stock Units | ||
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | 03 Feb 2022 | 1,399 | 7,697 (0%) | 0% | - | Common Stock | ||
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | 03 Feb 2022 | 1,138 | 11,403 | - | - | Restricted Stock Units | ||
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | 03 Feb 2022 | 1,138 | 6,298 (0%) | 0% | - | Common Stock | ||
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | 03 Feb 2022 | 1,079 | 5,160 (0%) | 0% | - | Common Stock | ||
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | 03 Feb 2022 | 1,079 | 12,541 | - | - | Restricted Stock Units | ||
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | 07 Dec 2021 | 873 | 4,081 (0%) | 0% | 101.5 | 88,610 | Common Stock | |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | 15 Nov 2021 | 569 | 4,954 (0%) | 0% | 102 | 58,038 | Common Stock | |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | 11 Nov 2021 | 1,111 | 5,523 (0%) | 0% | 100.7 | 111,922 | Common Stock | |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | 04 Nov 2021 | 1,398 | 6,634 (0%) | 0% | 101.8 | 142,274 | Common Stock | |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | 03 Nov 2021 | 1,277 | 8,032 (0%) | 0% | 99.6 | 127,234 | Common Stock | |
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | 23 Oct 2021 | 639 | 9,309 (0%) | 0% | - | Common Stock | ||
| Usana Health Sciences Inc | David Mulham | Chief Field Development Office | 23 Oct 2021 | 639 | 13,620 | - | - | Restricted Stock Units |